Our spinoff Captain T Cell has clinched 2nd prize among 70+ participants in the Startup Spotlight session at #bioeurope 2023! Congratulations on this well-deserved achievement!

Learn more on our therapeutics development:
https://www.mdc-berlin.de/transfer/innovation/therapeutics

#techtransfer #tcelltherapies

Therapeutics Development

Our researchers made a key contribution in drug and technology development. Prominent examples are VONVENDI (Baxalta Inc., now: Shire) and Blincyto (Amgen).